ZimVie Inc. (NASDAQ:ZIMV) Shares Acquired by JPMorgan Chase & Co.

JPMorgan Chase & Co. raised its stake in shares of ZimVie Inc. (NASDAQ:ZIMV) by 18.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 217,773 shares of the company’s stock after acquiring an additional 34,354 shares during the period. JPMorgan Chase & Co. owned approximately 0.79% of ZimVie worth $3,038,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Barclays PLC grew its position in ZimVie by 338.4% in the 3rd quarter. Barclays PLC now owns 43,437 shares of the company’s stock valued at $690,000 after buying an additional 33,529 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of ZimVie by 2.4% in the third quarter. Geode Capital Management LLC now owns 646,564 shares of the company’s stock valued at $10,263,000 after acquiring an additional 15,053 shares in the last quarter. Principal Financial Group Inc. purchased a new stake in shares of ZimVie in the third quarter valued at about $275,000. Monarch Capital Management Inc. increased its stake in shares of ZimVie by 6.2% during the fourth quarter. Monarch Capital Management Inc. now owns 65,560 shares of the company’s stock worth $915,000 after acquiring an additional 3,847 shares during the period. Finally, SG Americas Securities LLC raised its holdings in ZimVie by 15.7% during the fourth quarter. SG Americas Securities LLC now owns 11,110 shares of the company’s stock worth $155,000 after purchasing an additional 1,508 shares in the last quarter. 95.63% of the stock is currently owned by hedge funds and other institutional investors.

ZimVie Stock Performance

Shares of ZIMV opened at $8.92 on Tuesday. The company has a quick ratio of 1.38, a current ratio of 1.94 and a debt-to-equity ratio of 0.57. ZimVie Inc. has a 52-week low of $8.56 and a 52-week high of $22.40. The company has a 50-day simple moving average of $11.47 and a 200-day simple moving average of $13.21. The company has a market capitalization of $248.40 million, a PE ratio of -0.68 and a beta of 2.14.

ZimVie (NASDAQ:ZIMV) last issued its earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.25 by $0.02. The company had revenue of $111.52 million during the quarter, compared to analysts’ expectations of $113.67 million. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. Equities research analysts predict that ZimVie Inc. will post 0.6 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. B. Riley began coverage on ZimVie in a report on Thursday, April 10th. They issued a “buy” rating and a $16.00 price objective on the stock. Needham & Company LLC restated a “hold” rating on shares of ZimVie in a research note on Wednesday, April 9th.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.